ERBB2 and cancer: In situations wherein HER2 is highly overexpressed at the plasma membrane of certain cancer cells, the accumulation of transient interactions exerted by large numbers of HER2 molecules is likely sufficient to influence the membrane dynamics and endocytosis of EGFR.